Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study

International audience ; Background: Limited data are available regarding antiviral therapy efficacy in most severe patients under mechanical ventilation for Covid-19-related acute respiratory distress syndrome (ARDS).Methods: Comparison of antiviral strategies (none, hydroxychloroquine (OHQ), lopinavir/ritonavir (L/R), others (combination or remdesivir) in an observational multicentre cohort of patients with moderate-to-severe Covid-19 ARDS. The primary endpoint was the number of day 28 ventilator-free days (VFD). Patients who died before d28 were considered as having 0 VFD. The variable was... Mehr ...

Verfasser: Grimaldi, David
Aissaoui, Nadia
Blonz, Gauthier
Carbutti, Giuseppe
Courcelle, Romain
Gaudry, Stephane
Gaultier, Aurelie
D’hondt, Alain
Higny, Julien
Horlait, Geoffrey
Hraiech, Sami
Lefebvre, Laurent
Lejeune, Francois
Ly, Andre
Piagnerelli, Michael
Sauneuf, Bertrand
Serck, Nicolas
Soumagne, Thibaud
Szychowiak, Piotr
Textoris, Julien
Vandenbunder, Benoit
Vinsonneau, Christophe
Lascarrou, Jean- Baptiste
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Verlag/Hrsg.: HAL CCSD
Schlagwörter: Renal replacement therapy / Remdesivir / Lopinavir / Ritonavir / Acute kidney injury / Hydroxychloroquine / [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases / [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases / [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract / [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology / [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26530523
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hal.science/hal-03640594